BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia

Blood Cells, Molecules, and Diseases

Volumn 54, Issue 3, 2015, Pages 224-230

  Sebastiani, P ^a   Farrell, J J ^b   Alsultan, A ^c   Wang, S ^a   Edward, H L ^b   Shappell, H ^a   Bae, H ^d   Milton, J N ^a   Baldwin, C T ^b   Al Rubaish, A M ^e   Naserullah, Z ^f   Al Muhanna, F ^e   Alsuliman, A ^g   Patra, P K ^h   Farrer, L A ^b   Ngo, D ^b   Vathipadiekal, V ^b   Chui, D H K ^b   Al Ali, A K ^e   Steinberg, M H ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d OREGON STATE UNIVERSITY   (United States)

^e IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^f Maternity and Children's Hospital   (Saudi Arabia)

^g KING FAHAD HOSPITAL   (Saudi Arabia)

^h PT J N M MEDICAL COLLEGE   (India)

Author keywords

Genetic association; Haplotype analysis; Hemoglobin; Sickle cell disease

Indexed keywords

HEMOGLOBIN F; BCL11A PROTEIN, HUMAN; CARRIER PROTEIN; NUCLEAR PROTEIN;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARAB; ARTICLE; BCL11A GENE; BENIN; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ENHANCER REGION; ETHNIC DIFFERENCE; GENE; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOTE; HUMAN; INDIAN; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETICS; GENOTYPE; MALE; MIDDLE AGED;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANEMIA, SICKLE CELL; ARABS; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CHILD; FEMALE; FETAL HEMOGLOBIN; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84923834232     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2015.01.001     Document Type: Article

References (36)

1. Nagel R.L., Bookchin R.M., Johnson J., Labie D., Wajcman H., Isaac-Sodeye W.A., Honig G.R., Schiliro G., Crookston J.H., Matsutomo K. Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:670-672.
2. Poillon W.N., Kim B.C., Rodgers G.P., Noguchi C.T., Schechter A.N. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:5039-5043.
3. Akinsheye I., Solovieff N., Ngo D., Malek A., Sebastiani P., Steinberg M.H., Chui D.H. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. Am. J. Hematol. 2012, 87:217-219.
4. Steinberg M.H., Sebastiani P. Genetic modifiers of sickle cell disease. Am. J. Hematol. 2012, 87:795-803.
5. Nagel R.L., Rao S.K., Dunda-Belkhodja O., Connolly M.M., Fabry M.E., Georges A., Krishnamoorthy R., Labie D. The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. Blood 1987, 69:1026-1030.
6. Nagel R.L., Fabry M.E., Pagnier J., Zohoun I., Wajcman H., Baudin V., Labie D. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N. Engl. J. Med. 1985, 312:880-884.
7. Kulozik A.E., Wainscoat J.S., Serjeant G.R., Kar B.C., Al-Awamy B., Essan G.J., Falusi A.G., Haque S.K., Hilali A.M., Kate S., et al. Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am. J. Hum. Genet. 1986, 39:239-244.
8. Labie D., Srinivas R., Dunda O., Dode C., Lapoumeroulie C., Devi V., Devi S., Ramasami K., Elion J., Ducrocq R., et al. Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India. Hum. Biol. 1989, 61:479-491.
9. Perrine R.P., Brown M.J., Clegg J.B., Weatherall D.J., May A. Benign sickle-cell anaemia. Lancet 1972, 2:1163-1167.
10. Bauer D.E., Kamran S.C., Lessard S., Xu J., Fujiwara Y., Lin C., Shao Z., Canver M.C., Smith E.C., Pinello L., Sabo P.J., Vierstra J., Voit R.A., Yuan G.C., Porteus M.H., Stamatoyannopoulos J.A., Lettre G., Orkin S.H. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 2013, 342:253-257.
11. Perrine R.P., Pembrey M.E., John P., Perrine S., Shoup F. Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Ann. Intern. Med. 1978, 88:1-6.
12. Pembrey M.E., Wood W.G., Weatherall D.J., Perrine R.P. Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia. Br. J. Haematol. 1978, 40:415-429.
13. Alsultan A., Alabdulaali M.K., Griffin P.J., Alsuliman A.M., Ghabbour H.A., Sebastiani P., Albuali W.H., Al-Ali A.K., Chui D.H., Steinberg M.H. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. Br. J. Haematol. 2014, 164:597-604.
14. Italia K., Kangne H., Shanmukaiah C., Nadkarni A.H., Ghosh K., Colah R.B. Variable phenotypes of sickle cell disease in India with the Arab-Indian haplotype. Br. J. Haematol. 2014, 168(1):156-159.
15. Alsultan A., Solovieff N., Aleem A., AlGahtani F.H., Al-Shehri A., Osman M.E., Kurban K., Bahakim H., Al-Momen A.K., Baldwin C.T., Chui D.H., Steinberg M.H. Fetal hemoglobin in sickle cell anemia: Saudi patients from the Southwestern province have similar HBB haplotypes but higher HbF levels than African Americans. Am. J. Hematol. 2011, 86:612-614.
16. Ngo D., Bae H., Steinberg M.H., Sebastiani P., Solovieff N., Baldwin C.T., Melista E., Safaya S., Farrer L.A., Al-Suliman A.M., Albuali W.H., Al Bagshi M.H., Naserullah Z., Akinsheye I., Gallagher P., Luo H.Y., Chui D.H., Farrell J.J., Al-Ali A.K., Alsultan A. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype. Blood Cells Mol. Dis. 2013, 51:22-26.
17. Menzel S., Garner C., Gut I., Matsuda F., Yamaguchi M., Heath S., Foglio M., Zelenika D., Boland A., Rooks H., Best S., Spector T.D., Farrall M., Lathrop M., Thein S.L. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 2007, 39:1197-1199.
18. Sankaran V.G., Menne T.F., Xu J., Akie T.E., Lettre G., Van Handel B., Mikkola H.K., Hirschhorn J.N., Cantor A.B., Orkin S.H. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008, 322:1839-1842.
19. Sedgewick A.E., Timofeev N., Sebastiani P., So J.C., Ma E.S., Chan L.C., Fucharoen G., Fucharoen S., Barbosa C.G., Vardarajan B.N., Farrer L.A., Baldwin C.T., Steinberg M.H., Chui D.H. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol. Dis. 2008, 41:255-258.
20. Uda M., Galanello R., Sanna S., Lettre G., Sankaran V.G., Chen W., Usala G., Busonero F., Maschio A., Albai G., Piras M.G., Sestu N., Lai S., Dei M., Mulas A., Crisponi L., Naitza S., Asunis I., Deiana M., Nagaraja R., Perseu L., Satta S., Cipollina M.D., Sollaino C., Moi P., Hirschhorn J.N., Orkin S.H., Abecasis G.R., Schlessinger D., Cao A. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1620-1625.
21. Xu J., Peng C., Sankaran V.G., Shao Z., Esrick E.B., Chong B.G., Ippolito G.C., Fujiwara Y., Ebert B.L., Tucker P.W., Orkin S.H. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 2011, 334:993-996.
22. Solovieff N., Milton J.N., Hartley S.W., Sherva R., Sebastiani P., Dworkis D.A., Klings E.S., Farrer L.A., Garrett M.E., Ashley-Koch A., Telen M.J., Fucharoen S., Ha S.Y., Li C.K., Chui D.H., Baldwin C.T., Steinberg M.H. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood 2010, 115:1815-1822.
23. Gaston M., Rosse W.F. The cooperative study of sickle cell disease: review of study design and objectives. Am. J. Pediatr. Hematol. Oncol. 1982, 4:197-201.
24. Little S. Amplification-refractory mutation system (ARMS) analysis of point mutations. Curr. Protoc. Hum. Genet. 2001, http://dx.doi.org/10002/0471142905.hg0908s07, (Chapter 9, Unit 9 8).
25. Alsultan A., Ngo D.A., Farrell J.J., Akinsheye I., Solovieff N., Ghabbour H.A., Al-Ali A., Alsuliman A., Al-Baghshi M., Albu-Ali W., Alabdulaali M., Baldwin C.T., Farrer L.A., Luo H., Melista E., Safaya S., Nwaru M., Chui D.H., Steinberg M.H. A functional promoter polymorphism of the delta-globin gene is a specific marker of the Arab-Indian haplotype. Am. J. Hematol. 2012, 87:824-826.
26. Lake S.L., Lyon H., Tantisira K., Silverman E.K., Weiss S.T., Laird N.M., Schaid D.J. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum. Hered. 2003, 55:56-65.
27. Coon C.S. The Races of Europe 1939, Macmillan.
28. Facey W. The Story of the Eastern Province of Saudi Arabia 1994, Stacey International.
29. Solovieff N., Hartley S.W., Baldwin C.T., Klings E.S., Gladwin M.T., JGt Taylor, Kato G.J., Farrer L.A., Steinberg M.H., Sebastiani P. Ancestry of African Americans with sickle cell disease. Blood Cells Mol. Dis. 2011, 47:41-45.
30. Galarneau G., Palmer C.D., Sankaran V.G., Orkin S.H., Hirschhorn J.N., Lettre G. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat. Genet. 2010, 42:1049-1051.
31. Bae H.T., Baldwin C.T., Sebastiani P., Telen M.J., Ashley-Koch A., Garrett M., Hooper W.C., Bean C.J., Debaun M.R., Arking D.E., Bhatnagar P., Casella J.F., Keefer J.R., Barron-Casella E., Gordeuk V., Kato G.J., Minniti C., Taylor J., Campbell A., Luchtman-Jones L., Hoppe C., Gladwin M.T., Zhang Y., Steinberg M.H. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 2012, 120:1961-1962.
32. Jiang J., Best S., Menzel S., Silver N., Lai M.I., Surdulescu G.L., Spector T.D., Thein S.L. cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 2006, 108:1077-1083.
33. Lettre G., Sankaran V.G., Bezerra M.A., Araujo A.S., Uda M., Sanna S., Cao A., Schlessinger D., Costa F.F., Hirschhorn J.N., Orkin S.H. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11869-11874.
34. Bhatnagar P., Purvis S., Barron-Casella E., DeBaun M.R., Casella J.F., Arking D.E., Keefer J.R. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J. Hum. Genet. 2011, 56:316-323.
35. Sankaran V.G., Xu J., Byron R., Greisman H.A., Fisher C., Weatherall D.J., Sabath D.E., Groudine M., Orkin S.H., Premawardhena A., Bender M.A. A functional element necessary for fetal hemoglobin silencing. N. Engl. J. Med. 2011, 365:807-814.
36. Campbell A.D., Cui S., Shi L., Urbonya R., Mathias A., Bradley K., Bonsu K.O., Douglas R.R., Halford B., Schmidt L., Harro D., Giacherio D., Tanimoto K., Tanabe O., Engel J.D. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18808-18813.